CYP7A1 and metabolic dysfunction-associated steatotic liver disease: Zheng et al. [61] found that astragalus polysaccharide attenuated HFD-induced MASLD by inhibiting BA synthesis of key factors of the classical pathway (e.g., CYP7A1 and CYP8B1) by facilitating the alternative pathway.